Methods in Pharmacoepidemiology / Other

((A-199)) (A-199) 10 Practical considerations for the conduct of multinational studies in pharmacoepidemiology

((A-200)) (A-200) Strengthening inferential studies in the U.S. FDA Sentinel initiative: Results from a methodological demonstration project

((A-201)) (A-201) An evidence base to support the establishment of a fit-for-purpose quality management system for secondary data pharmacoepidemiological studies

((A-202)) (A-202) Active Safety Surveillance Using Real-world Evidence (ASSURE) Implementation: Transparent and Reproducible Real-World Evidence (RWE) Standardized Framework to Support Safety Signal Evaluation

((A-203)) (A-203) Evaluating Result Consistency of OMOP and Sentinel Common Data Models: A Case Study of Hospitalized Atherosclerotic Cardiovascular Disease Patients in Taiwan

((A-204)) (A-204) Clearing Real-World Data Quality Hurdles: Characterizing Quality Attributes of the Guardian Research Network in the Context of Regulatory Submission

((A-205)) (A-205) Electronic Health Record (EHR) Enhanced Signal Detection Using Tree-Based Scan Statistic Methods

((A-206)) (A-206) Assessing Core Competencies in Pharmacoepidemiology Training Programs: A Global Needs Assessment

((A-207)) (A-207) Epidemiologic Challenges in Using Claims Data to Study Opioid Use Disorder Treatment Trajectories

((A-208)) (A-208) Development and Validation of a Modern Prescription-Based Risk Score Predicting Healthcare Spending and Utilization

((A-209)) (A-209) Developing Validation Tool for Claim-Based Pregnancy Outcomes: The Pregnancy Algorithm CErtaInty Tool (Pregnancy ACE-IT)

((A-210)) (A-210) Validation and improvement of an algorithm identifying relapses in multiple sclerosis (MS) within the French nationwide claims database

((A-211)) (A-211) Real-World Data for Evidence Generation Supporting FDA Approvals for Labeling Extension of Drugs and Biologics

((A-212)) (A-212) Towards Accurate Data Linkage: A Comparison of Deterministic, Probabilistic, and Machine Learning Approaches Applications in Multiple Sclerosis

((A-213)) (A-213) Development and Validation of Claim-based Algorithms for Non-Melanoma Skin Cancer Using Optum Integrated Databases

((A-214)) (A-214) Harmonizing Electronic Health Records from Multi-Healthcare Systems in Saudi Arabia: A Comprehensive Guide with SQL Script

((A-215)) (A-215) EpiCore - a common data model for Scandinavian pharmacoepidemiological studies

((A-216)) (A-216) Exploring and Characterizing Glioblastoma Data from a Real-world Clinical Platform

((A-217)) (A-217) Observed rate of safety outcomes, vaccinations, and healthcare utilization in elderly persons with Commercial vs Medicare Advantage insurance in a US Claims Database

((A-218)) (A-218) Onboarding and characterising NHS health data in the HEalth Data Research UK RWE OMOP Network (HERON-UK)

((A-219)) (A-219) Characterization of Healthcare Providers of a Cohort of Patients from Claims Data Based on Propagated Information from Linkage to Patient Encounters

((A-220)) (A-220) Concordance of Electronic Health Record Data and Medicare Part D Claims Data among Beneficiaries Prescribed Antihypertensive Medications

((A-221)) (A-221) Self-Reported Use of Non-FDA Approved Cannabinoid Products among Hospitalized Patients in a Large US Hospital Network

((C-142)) (C-142) National Surveys in Health Outcomes, Pharmacoepidemiology, and Pharmacy Practice Research